Vaccines

It’s been a busy time for infectious disease vaccine news in Europe.

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

With mRNA offering more straightforward development and manufacturing processes, are the days of traditional vaccine modalities numbered?

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Our eBook features mRNA vs malaria, vaccines, top tips for mRNA sequencing, and more

What did the industry learn about logistics during COVID vaccine rollout, and how will it make sure nobody gets left behind?

A technique comparable to the alternative medicinal practice of “cupping” has shown potential in improving delivery of nucleic acid medicines.

Panels, thought leaders, and spicy opinions! Here’s a roundup of our best video content of 2021.

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.